A review of therapeutic agents for the management of pulmonary arterial hypertension

被引：10

作者：

Hahn, Stella S. ^{[1
]}

Makaryus, Mina ^{[1
]}

Talwar, Arunabh ^{[1
]}

Narasimhan, Mangala ^{[1
]}

Zaidi, Gulrukh ^{[1
]}

机构：

[1] Northwell Hlth, Div Pulm Crit Care & Sleep Med, 410 Lakeville Rd,Suite 107, New Hyde Pk, NY 11042 USA

来源：

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | 2017年 / 11卷 / 01期

关键词：

pulmonary arterial hypertension; prostanoid; endothelin receptor antagonist; phosphodiesterase inhibitor; soluble guanylate cyclase stimulator; ENDOTHELIN RECEPTOR ANTAGONIST; RANDOMIZED CONTROLLED-TRIAL; CONTINUOUS INTRAVENOUS EPOPROSTENOL; NITRIC-OXIDE SYNTHASE; 5 INHIBITOR THERAPY; DOUBLE-BLIND; INHALED ILOPROST; ORAL TREPROSTINIL; COMBINATION THERAPY; PROSTACYCLIN ANALOG;

D O I：

10.1177/1753465816665289

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Pulmonary arterial hypertension (PAH) is an uncommon, progressive and life threatening disease characterized by a proliferative vasculopathy of the small muscular pulmonary arterioles resulting in elevated pulmonary vascular resistance and eventually right ventricular failure. An increasing understanding of the pathobiology of PAH and its natural history has led to the development of numerous targeted therapies. Despite these advances there is significant progression of disease and the survival rate remains low. This article reviews the agents currently available for the medical management of PAH.

引用

页码：46 / 63

页数：18

共 50 条

[41] Pulmonary arterial hypertension [J].

Boucly, Athenais ;

Gerges, Christian ;

Savale, Laurent ;

Jais, Xavier ;

Jevnikar, Mitja ;

Montani, David ;

Sitbon, Olivier ;

Humbert, Marc .

PRESSE MEDICALE, 2023, 52 (03)

[42] An Update on the Evaluation and Management of Pulmonary Hypertension in Scleroderma [J].

Coghlan, John G. ;

Schrieber, Benjamin .

CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (01) :1-10

[43] Therapeutic targets in pulmonary arterial hypertension [J].

Rhodes, Christopher J. ;

Davidson, Alexandra ;

Gibbs, J. Simon R. ;

Wharton, John ;

Wilkins, Martin R. .

PHARMACOLOGY & THERAPEUTICS, 2009, 121 (01) :69-88

[44] Pulmonary Arterial Hypertension Related to Connective Tissue Disease: A Review [J].

Ahmed, Saman ;

Palevsky, Harold I. .

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2014, 40 (01) :103-+

[45] Prostanoid therapies in the management of pulmonary arterial hypertension [J].

Le Varge, Barbara L. .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 :535-547

[46] Update on Medical Management of Pulmonary Arterial Hypertension [J].

Sherman, Alexander E. ;

Saggar, Rajan ;

Channick, Richard N. .

CARDIOLOGY CLINICS, 2022, 40 (01) :13-27

[47] Pulmonary Arterial Hypertension: Changing Approaches to Management [J].

Sidorenko, B. A. ;

Preobrazhensky, D. V. ;

Batyraliev, T. A. ;

Belenkov, Yu. N. .

KARDIOLOGIYA, 2011, 51 (01) :100-108

[48] Selexipag in the management of pulmonary arterial hypertension: an update [J].

Coghlan, J. Gerry ;

Picken, Christina ;

Clapp, Lucie H. .

DRUG HEALTHCARE AND PATIENT SAFETY, 2019, 11 :55-64

[49] A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension [J].

Mubarak, Kamal K. .

RESPIRATORY MEDICINE, 2010, 104 (01) :9-21

[50] Oral treprostinil diethanolamine for pulmonary arterial hypertension [J].

Feldman, Jeremy ;

Im, Yunhee ;

Gill, Kirat .

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) :55-60

← 1 2 3 4 5 →